Christopher Lowe

Christopher P.
Lowe is Chief Executive Officer at Nusano, Inc. since 2022 and Director at Pacific Pharmaceutical Services LLC.
Former roles include President, Chief Executive Officer & Director at Rebus Holdings, Inc. from 2016 to 2018; Director at Asante Solutions, Inc. from 2014 to 2015; Director at Pacific Pharmaceuticals, Inc. from 2010 to 2014; Director at EpiBiome, Inc. from 2016 to 2018; Director at Career Closet, Inc. from 2009 to 2014; Independent Director at Vincerx Pharma, Inc. from 2020 to 2022; Director at Inspyr Therapeutics, Inc. from 2016 to 2018; Global Controller-Trane Division at American Standard Cos., Inc. from 2003 to 2004; Chief Accounting Officer at Peninsula Pharmaceuticals, Inc. from 2004 to 2005; Chief Executive & Financial Officer at Hansen Medical, Inc. from 2014 to 2016; Chief Financial Officer & VP-Administration at Asthmatx, Inc. in 2007; CFO, Chief Business Officer & VP-Administration at Anthera Pharmaceuticals, Inc. from 2012 to 2013; Chief Financial Officer at SentreHEART, Inc. from 2015 to 2018; Chief Financial Officer at Liquid Light, Inc.; Chief Financial Officer & Executive Vice President at Microlin Bio, Inc.; Vice President-Research & Development at Dow Chemical Canada ULC; Chief Financial & Accounting Officer at Diadexus, Inc. from 2014 to 2015; Partner at FLG Partners LLC from 2014 to 2020; Chief Operating & Financial Officer at Quince Therapeutics, Inc. in 2022; Managing Partner-Innventus Fund at Innventure Management Services LLC in 2020; Chief Financial Officer & Secretary at biOasis Technologies, Inc. from 2017 to 2019.
Education includes an MBA from St. Mary's University and undergraduate studies at California Polytechnic State University (San Luis Obispo).